[go: up one dir, main page]

UY34096A - Soporte de colageno enrollado - Google Patents

Soporte de colageno enrollado

Info

Publication number
UY34096A
UY34096A UY0001034096A UY34096A UY34096A UY 34096 A UY34096 A UY 34096A UY 0001034096 A UY0001034096 A UY 0001034096A UY 34096 A UY34096 A UY 34096A UY 34096 A UY34096 A UY 34096A
Authority
UY
Uruguay
Prior art keywords
collagen support
compressed
support coil
rolled
collagen
Prior art date
Application number
UY0001034096A
Other languages
English (en)
Inventor
Dybendal Pedersen Pernille
Poul Bertelsen
Br/Ender Henrik
Ingrid Blanka
Schönhofer Wolfgang
Neuschäfer Larsen Henrik
Original Assignee
Nycomed Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Pharma As filed Critical Nycomed Pharma As
Publication of UY34096A publication Critical patent/UY34096A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/041—Mixtures of macromolecular compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A61F13/0276—Apparatus or processes for manufacturing adhesive dressings or bandages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/043—Mixtures of macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Manufacturing & Machinery (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Diabetes (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Prostheses (AREA)

Abstract

Un proceso para la preparación de un soporte de colágeno comprimido enrollado y un proceso para desenrollar dicho soporte de colágeno comprimido enrollado. Dicho soporte de colágeno comprimido enrollado está listo para su uso en una cirugía mínimamente invasiva. La invención también se relaciona con un soporte de colágeno comprimido enrollado para su uso en la prevención o el tratamiento de una lesión asociada con la realización de una cirugía mínimamente invasiva.
UY0001034096A 2011-05-24 2012-05-24 Soporte de colageno enrollado UY34096A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11167379 2011-05-24

Publications (1)

Publication Number Publication Date
UY34096A true UY34096A (es) 2018-06-29

Family

ID=44692373

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001034096A UY34096A (es) 2011-05-24 2012-05-24 Soporte de colageno enrollado

Country Status (38)

Country Link
US (2) US9814686B2 (es)
EP (2) EP3243489B8 (es)
JP (1) JP6025824B2 (es)
KR (1) KR101833035B1 (es)
CN (1) CN103702645B (es)
AP (1) AP2013007327A0 (es)
AR (1) AR086557A1 (es)
AU (1) AU2012261339B2 (es)
BR (1) BR112013029709B1 (es)
CA (1) CA2837117C (es)
CL (1) CL2013003274A1 (es)
CO (1) CO6862131A2 (es)
CY (1) CY1119313T1 (es)
DK (2) DK3243489T3 (es)
EA (1) EA028878B1 (es)
ES (2) ES2642151T3 (es)
GE (1) GEP201706715B (es)
HR (1) HRP20171424T1 (es)
HU (1) HUE032689T4 (es)
IL (1) IL229446A (es)
LT (1) LT2713972T (es)
MD (1) MD4471C1 (es)
ME (1) ME02830B (es)
MX (1) MX355925B (es)
MY (1) MY185054A (es)
PE (1) PE20141037A1 (es)
PH (1) PH12013502432A1 (es)
PL (2) PL2713972T3 (es)
PT (1) PT2713972T (es)
RS (1) RS56367B1 (es)
SA (1) SA112330549B1 (es)
SI (1) SI2713972T1 (es)
TN (1) TN2013000391A1 (es)
TW (1) TWI552774B (es)
UA (1) UA113959C2 (es)
UY (1) UY34096A (es)
WO (1) WO2012159635A1 (es)
ZA (1) ZA201307060B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12013502432A1 (en) 2011-05-24 2014-01-13 Takeda As Rolled collagen carrier
CA2871697C (en) 2012-05-24 2020-08-25 Takeda Nycomed As Apparatus and process for providing a coiled collagen carrier
JP6242874B2 (ja) 2012-05-24 2017-12-06 タケダ エイエスＴａｋｅｄａ ＡＳ パッケージ
GB2543307B (en) * 2015-10-14 2020-12-09 Selentus Science Ltd Haemostatic device
WO2018051205A1 (es) * 2016-09-16 2018-03-22 Universidad De Los Andes Tapón hemostático de matriz extracelular para biopsias percutáneas y aparato para su fabricación
MD1169Z (ro) * 2016-12-06 2018-02-28 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Metodă de obţinere a spongiei de colagen
EP3902573A4 (en) * 2018-12-28 2022-08-24 Excel Med, LLC Biological scaffold and method for fabricating the same
DE102019213178A1 (de) * 2019-08-30 2021-03-04 Resorba Medical Gmbh Polymerfolie und Polymertasche zur Aufnahme eines zu implantierenden medizinisch-technischen Produkts
CN111839637B (zh) * 2020-09-04 2022-05-10 青岛市市北区蓝天心理研究所 一种妇科伤口缝合辅助装置
CA3194691A1 (en) * 2020-11-05 2022-05-12 Ran Kapri Multi-layered collagen structure
CN117919517A (zh) * 2024-01-26 2024-04-26 陕西省眼科研究所 去细胞角膜基质板层组织联合生物胶泪道栓及其制备方法

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE404337A (es) 1933-02-11 1900-01-01
GB423017A (en) 1934-05-24 1935-01-23 Koninklijke Pharma Fab Nv A process and apparatus for the manufacture of threads, strings, bands, films and the like from animal fibres
GB487258A (en) 1936-02-07 1938-06-17 Koninklijke Pharma Fab Nv Tampons and other porous articles, such as sheaths and bandages, and a process for producing same
DE3105624A1 (de) * 1981-02-16 1982-09-02 Hormon-Chemie München GmbH, 8000 München Material zum abdichten und heilen von wunden
US5147387A (en) 1990-10-10 1992-09-15 W. L. Gore & Associates, Inc. Process of implanting a prosthetic sheet repair material
US5290310A (en) 1991-10-30 1994-03-01 Howmedica, Inc. Hemostatic implant introducer
RU2018540C1 (ru) 1992-11-23 1994-08-30 Товарищество с ограниченной ответственностью Фирма "Копримекс" Способ получения коллагенсодержащего материала
US5334216A (en) 1992-12-10 1994-08-02 Howmedica Inc. Hemostatic plug
US5942278A (en) 1993-03-31 1999-08-24 Nycomed Arzneimittel Gmbh Process for the production of a material for sealing and healing wounds
US6177126B1 (en) 1993-03-31 2001-01-23 Nycomed Arzneimittel Gmbh Process for the production of a material for sealing and healing wounds
AT410754B (de) * 1993-03-31 2003-07-25 Nycomed Austria Gmbh Vorrichtung zum gleichmässigen auftragen einer suspension auf einen kollagenträger
AT402683B (de) 1995-05-16 1997-07-25 Hafslund Nycomed Pharma Gerät für endoskopische oder laparoskopische applikation von chirurgischem material
DE69610437T2 (de) 1995-12-13 2001-04-19 Nycomed Arzneimittel Gmbh Applikator für chirurgisches material
DE19546435A1 (de) 1995-12-13 1997-06-19 Nycomed Arzneimittel Gmbh Vorrichtung zum Einbringen von wundheilendem oder wundversiegelnden Material in den Körper
RU2118176C1 (ru) 1996-09-27 1998-08-27 Истранов Леонид Прокофьевич Способ получения коллагеновых пластинок
EP1009291B8 (en) 1997-03-20 2006-01-11 Genzyme Corporation Biodegradable tissue retractor
FR2777284B1 (fr) * 1998-04-10 2000-05-26 Hamza Mansour Procede de sterilisation d'un collagene natif en milieu liquide, collagene natif sterile obtenu, compositions le contenant et applications
DE19922078A1 (de) 1999-05-15 2000-11-23 Weitzel Kage Doris Gewebekonstrukt für die Transplantationschirurgie
CN1246047C (zh) 2001-01-25 2006-03-22 奈科明医药有限公司 含纤维蛋白原、凝血酶和醇的悬浮液及其涂敷载体的方法
US20020164322A1 (en) * 2001-01-25 2002-11-07 Alfred Schaufler Suspension comprising fibrinogen, thrombin and alcohol, a method for preparing such a suspension, a method for coating a carrier with such a suspension, a method of drying a coating of a carrier, and a coated collagen sponge
US7098315B2 (en) * 2001-01-25 2006-08-29 Nycomed Pharma As Method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge
US7052713B2 (en) 2001-02-13 2006-05-30 Nycomed Pharma As Carrier with solid fibrinogen and solid thrombin
MXPA03009356A (es) 2001-04-13 2004-01-29 I Flow Corp Recipiente esteril para aplicaciones medicas.
US8465516B2 (en) * 2001-07-26 2013-06-18 Oregon Health Science University Bodily lumen closure apparatus and method
AU2002326451B2 (en) 2001-07-26 2008-04-17 Cook Biotech Incorporated Vessel closure member and delivery apparatus
TWI324524B (en) * 2002-01-25 2010-05-11 Nycomed Pharma As Carrier with solid fibrinogen and solid thrombin
US6998510B2 (en) 2002-02-04 2006-02-14 Damage Control Surgical Technologies, Inc. Method and apparatus for improved hemostasis and damage control operations
US7166133B2 (en) 2002-06-13 2007-01-23 Kensey Nash Corporation Devices and methods for treating defects in the tissue of a living being
JP4581318B2 (ja) 2002-08-09 2010-11-17 ニプロ株式会社 生分解性筒状体およびそれを用いた生体組織または器官再生器具
JP4168740B2 (ja) 2002-12-12 2008-10-22 ニプロ株式会社 コラーゲン製人工血管
US7329792B2 (en) 2003-02-04 2008-02-12 Damage Control Surgical Technologies, Inc. Method and apparatus for hemostasis
RU2235539C1 (ru) 2003-04-25 2004-09-10 Филатов Владимир Николаевич Способ получения порошкообразного материала для остановки кровотечений
CN1251655C (zh) * 2003-06-13 2006-04-19 常春荣 快速生物封闭止血装置及其制造工艺
US20050208095A1 (en) 2003-11-20 2005-09-22 Angiotech International Ag Polymer compositions and methods for their use
CN2705167Y (zh) * 2004-02-20 2005-06-22 佟刚 胶原贴敷料
WO2005123171A2 (en) * 2004-06-09 2005-12-29 Stout Medical Group Lp Three-dimensional coils for treatment of vascular aneurysms
GB0415080D0 (en) 2004-07-05 2004-08-04 Ucl Biomedica Plc Methods for preparing tissue equivalent implants and products thereof
EP2052746B1 (en) 2004-10-20 2014-11-26 Ethicon, Inc. Absorbable hemostat
JP4995811B2 (ja) 2005-04-29 2012-08-08 クック・バイオテック・インコーポレーテッド 瘻治療用容積式移植片並びに関連の方法及びシステム
JP4765602B2 (ja) 2005-12-14 2011-09-07 ニプロ株式会社 再生医療用器具の包装体及び再生医療用器具用の処理方法
US8795709B2 (en) 2006-03-29 2014-08-05 Incept Llc Superabsorbent, freeze dried hydrogels for medical applications
NZ574653A (en) * 2006-08-04 2012-11-30 Stb Lifesaving Technologies Inc Solid dressing for treating wounded tissue
US8299316B2 (en) * 2007-12-18 2012-10-30 Ethicon, Inc. Hemostatic device
AU2009220808B2 (en) 2008-03-03 2014-01-16 Omrix Biopharmaceuticals Ltd. A gelatin sponge comprising an active ingredient, its preparation and use
CA2721162C (en) 2008-04-11 2017-03-14 Virginia Commonwealth University Electrospun dextran fibers and devices formed therefrom
US20090275129A1 (en) 2008-04-30 2009-11-05 Ethicon, Inc. Tissue engineered blood vessels
CN102076364B (zh) 2008-05-02 2014-07-02 普罗维登斯医疗卫生系统-俄勒冈州D/B/A普罗维登斯圣文森特医疗中心 创伤敷裹装置和方法
JP5157689B2 (ja) * 2008-07-07 2013-03-06 ニプロ株式会社 内視鏡下手術用デバイス
US9061464B2 (en) 2008-09-03 2015-06-23 Collagen Matrix, Inc. Re-rollable wrapping implant
US8529434B2 (en) 2008-10-29 2013-09-10 Cook Medical Technologies Llc Endoscopic sheet delivery
CN201342005Y (zh) * 2009-02-02 2009-11-11 沂南县天成生物制品有限公司 一种壳聚糖复合生物止血膜
US8926552B2 (en) 2009-08-12 2015-01-06 Medtronic, Inc. Particle delivery
PH12013502432A1 (en) 2011-05-24 2014-01-13 Takeda As Rolled collagen carrier

Also Published As

Publication number Publication date
EA201391716A1 (ru) 2014-03-31
CL2013003274A1 (es) 2014-06-20
BR112013029709B1 (pt) 2021-07-20
HRP20171424T1 (hr) 2017-11-03
CA2837117C (en) 2017-08-29
AU2012261339B2 (en) 2014-06-12
EP2713972A1 (en) 2014-04-09
PH12013502432A1 (en) 2014-01-13
MD20130097A2 (ro) 2014-06-30
JP6025824B2 (ja) 2016-11-16
CO6862131A2 (es) 2014-02-10
IL229446A (en) 2017-06-29
AP2013007327A0 (en) 2013-12-31
CY1119313T1 (el) 2018-02-14
SA112330549B1 (ar) 2016-03-02
CN103702645B (zh) 2015-10-21
MY185054A (en) 2021-04-30
SI2713972T1 (sl) 2017-10-30
JP2014519897A (ja) 2014-08-21
DK2713972T3 (en) 2017-10-09
NZ615820A (en) 2015-10-30
LT2713972T (lt) 2017-09-11
ME02830B (me) 2018-01-20
TWI552774B (zh) 2016-10-11
ES2871064T3 (es) 2021-10-28
EP2713972B9 (en) 2017-11-15
MD4471C1 (ro) 2017-10-31
TN2013000391A1 (en) 2015-01-20
PL2713972T3 (pl) 2017-11-30
AR086557A1 (es) 2014-01-08
CA2837117A1 (en) 2012-11-29
AU2012261339A1 (en) 2013-03-07
CN103702645A (zh) 2014-04-02
TW201300143A (zh) 2013-01-01
MX2013013435A (es) 2014-07-09
PE20141037A1 (es) 2014-08-27
KR101833035B1 (ko) 2018-02-27
HUE032689T4 (en) 2017-11-28
PL3243489T3 (pl) 2021-11-02
KR20140033425A (ko) 2014-03-18
GEP201706715B (en) 2017-08-10
DK3243489T3 (da) 2021-05-10
US20180085322A1 (en) 2018-03-29
ES2642151T3 (es) 2017-11-15
MX355925B (es) 2018-05-04
IL229446A0 (en) 2014-01-30
EP3243489A1 (en) 2017-11-15
BR112013029709A2 (pt) 2020-12-15
US20140072612A1 (en) 2014-03-13
EA028878B1 (ru) 2018-01-31
WO2012159635A1 (en) 2012-11-29
EP3243489B8 (en) 2022-03-23
HUE032689T2 (en) 2017-10-30
PT2713972T (pt) 2017-09-22
US9814686B2 (en) 2017-11-14
US10532032B2 (en) 2020-01-14
RS56367B1 (sr) 2017-12-29
EP3243489B1 (en) 2021-02-17
ZA201307060B (en) 2014-05-28
ES2642151T9 (es) 2018-01-08
MD4471B1 (ro) 2017-03-31
EP2713972B1 (en) 2017-06-28
UA113959C2 (xx) 2017-04-10

Similar Documents

Publication Publication Date Title
UY34096A (es) Soporte de colageno enrollado
CL2014000630A1 (es) Una composicion que comprende 1) un compuesto derivado de nucleosido denominado como compuesto 10 y 2) un compuesto derivado de acido 5-tiofeno-2-carboxilico denominado como compuesto 5 o un compuesto derivado del ester metilico del acido carbamico denominado como compuesto 6; y su uso para el tratamiento profilactico o terapeutico de una infeccion por vhc.
BR112014005914A2 (pt) Produto para cicatrização de feridas tecidulares
DK2897625T3 (da) Amnionmembran og anvendelse deraf til sårheling og tissue engineering-konstrukter
EA202091303A3 (ru) Композиция ингибитора jak для местного применения
CO6900138A2 (es) Nuevos sulfóxidos de piperidino-dihidrotienopirimidina y su uso para tratar epoc y asma
CL2012003722A1 (es) Compuestos derivados del acido naf-2-ilacetico; composicion farmaceutica; y uso para el tratamiento del sida.
CL2013000801A1 (es) Composicion farmaceutica que comprende un inhibidor de rankl y una hormona o un derivado de la misma, y uso del inhibidor rankl para preparar dicha composicion
CO6300844A2 (es) Dihidropirazolonas sustituidas como inhibidores de hif-propil-4-hidroxilasa
CO6640327A2 (es) Compuestos de pirazol como inhibidores del receptor sigma
BR112012029746A2 (pt) composição para tratamento da pele, método para fornecer um efeito microbicida para pele e uso de uma combinação
CL2013001579A1 (es) Uso de una composicion farmaceutica que comprende un compuesto agonista ep4 para tratar marcas de la piel tales como heridas superficiales, cicatrices o arrugas.
MX2014000781A (es) Dosis combinada fija de bimatoprost y brimonidina.
CL2014000050A1 (es) Composicion farmaceutica en forma de solucion que comprende apomorfina, un codisolvente micible en agua, un antioxidante y agua, en la que el ph es superior a 4; procedimiento para fabricarla; y su uso como solucion inyectable en el tratamiento de la enfermedad de parkinson.
CA2863809A1 (en) Prophylactic or therapeutic agent for idiopathic inflammatory myopathies
CL2013002129A1 (es) Compuestos derivados de acido 3-heteroaroilamino-propionico sustituidos, como inhibidores de la proteasa catepsina a; procedimiento de preparacion; composicion farmaceutica que los comprende; y su uso para el tratamiento de insuficiencia cardiaca, enfermedades inmunologicas, asma, dolor, entre otras.
ECSP12012102A (es) Proceso para producir un extracto de alérgenos
PE20150167A1 (es) (r)-nifuratel, su uso para el tratamiento de las infecciones y sintesis de (r) y (s)-nifuratel
CO6801728A2 (es) Formulación de lipomosas adecuada para tratar o prevenir la tuberculosis
CL2015000537A1 (es) Siarn y su uso en los métodos y composiciones para el tratamiento y/o prevención de enfermedades de los ojos.
BR112015006960A2 (pt) uso de uma combinação, composição e método para preparar um produto de espuma
UY33662A (es) Combinaciones que comprenden inhibidores de dhodh e inhibidores de cox
CL2015001502A1 (es) Composición farmacéutica que comprende desloratadina y prendnisolona y uso de la misma.
AR084169A1 (es) Combinacion que comprende un derivado de la familia de las combretastatinas y cetuximab
MX2017011904A (es) Composiciones para el tratamiento de fibrosis y afecciones relacionadas con fibrosis.